Cart
sales@molnova.com
CY-09
CAS No. 1073612-91-5
CY-09( NLRP3 inhibitor CY-09 )
Catalog No. M10304 CAS No. 1073612-91-5
CY-09 (NLRP3 inhibitor CY-09) is a selective and direct NLRP3 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 52 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 112 | In Stock |
|
| 25MG | 235 | In Stock |
|
| 50MG | 365 | In Stock |
|
| 100MG | 548 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1237 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCY-09
-
NoteResearch use only, not for human use.
-
Brief DescriptionCY-09 (NLRP3 inhibitor CY-09) is a selective and direct NLRP3 inhibitor.
-
DescriptionCY-09 (NLRP3 inhibitor CY-09) is a selective and direct NLRP3 inhibitor, binds to the ATP-binding motif of NLRP3 NACHT domain and inhibits NLRP3 ATPase activity; suppresses NLRP3 inflammasome assembly and activation, shows remarkable therapeutic effects on mouse models of cryopyrin-associated autoinflammatory syndrome (CAPS) and type 2 diabetes.
-
In Vitro——
-
In Vivo——
-
SynonymsNLRP3 inhibitor CY-09
-
PathwayNF-κB
-
TargetNOD
-
RecptorNLRP3|NLRP3?inhibitor
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number1073612-91-5
-
Formula Weight423.424
-
Molecular FormulaC19H12F3NO3S2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 77 mg/mL (181.8 mM) （ < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(O)C1=CC=C(/C=C(SC(N2CC3=CC=CC(C(F)(F)F)=C3)=S)\C2=O)C=C1
-
Chemical NameBenzoic acid, 4-[[4-oxo-2-thioxo-3-[[3-(trifluoromethyl)phenyl]methyl]-5-thiazolidinylidene]methyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jiang H, et al. J Exp Med. 2017 Nov 6;214(11):3219-3238.
molnova catalog
related products
-
Asymmetric dimethyla...
Asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase (NOS).
-
NLRP3-IN-13
NLRP3-IN-13 is a selective NLRP3 inhibitor that inhibits NLRP3-associated inflammation.NLRP3-IN-13 can be used in the study of neurological disorders and inflammation.
-
Molsidomine
Molsidomine is an orally active, long acting vasodilating drug, metabolized in the liver to the active metabolite linsidomine.
